Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Birth Of A Giant: A Timeline Of Teva And Allergan's Generics Business

Executive Summary

Graphical timeline tracks the deals that shaped the two firms from turn of the last century to the present day.

You may also be interested in...



Merck's Biosims Business: What's For Sale And Who Will Buy It?

Merck KGaA is getting out of biosimilars – a unit that CEO Stefan Oschmann called the company's now redundant back up plan – to instead focus on its growing oncology pipeline, which includes recently acquired pipeline candidates from Vertex Pharma.

Merck's Biosims Business: What's For Sale And Who Will Buy It?

Merck KGaA is getting out of biosimilars – a unit that CEO Stefan Oschmann called the company's now redundant back up plan – to instead focus on its growing oncology pipeline, which includes recently acquired pipeline candidates from Vertex Pharma.

Teva, Allergan Generics: FTC Worried About A Multitude Of Markets, Not A Behemoth

Record-setting divestment order driven by sheer number of products where firms competed, not size of company that would result from acquisition.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC097008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel